GCP Auditor 36

Auditor boasts over a decade of expertise in clinical areas, including 3+ years in clinical quality assurance and over 10 years in pharmacovigilance management within multinational pharmaceutical giants. He's distinguished for his involvement in translating Pharmacovigilance literature and holds a prominent role as an expert panelist at the China Food and Drug Industries Quality and Safety Promotion Association. As a member of the China Institute of Internal Audit (CIIA), He specializes in GCP, GVP audit, supplier assessment, and regulatory audits. His portfolio includes over 250 audits of research centers, CROs, and pharma firms. His educational background encompasses a Ph.D. in Psychology from UCAM (Spain), a Master's in Pharmacology, and a Bachelor's in Pharmacy. His recent roles encompass leadership positions at Accestra Consulting, Bayer China, and Beijing Shenzhou Cell Group, demonstrating his proficiency in pharmacovigilance, clinical quality, and regulatory compliance.